Tecogen Inc.
AMEX:TGENElectrical Equipment & Parts
+$0.24 today
- Market cap
- $53.43M
- Beta
- 2.09
- P/E (TTM)
- -18.5
- EPS (TTM)
- -$0.33
Volume 0.08M
Average 0.56M
TGEN Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
Tecogen Inc.AMEX: TGEN
Free Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Free cash flow growth accelerates
Q1 FY2026 free cash flow of $3.15M (cash outflow) rose 141.6% year over year, ahead of the -840.3% change in trailing-twelve-month free cash flow. Sequentially, it rose 20.3% from the prior quarter. Over 3 fiscal years it compounded at +82.5% a year.
Context
- Free cash flow amounted to 38.1% of revenue in FY2025, up 24.4 pp from a year earlier.
- Free cash flow increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +141.6% holds above the trailing-twelve-month pace of -840.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (10.31M) USD
- Year-over-year change
- -433.6%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (10.31M) | -433.6% |
| FY2024 | 2024-12-31 | 3.09M | +457.5% |
| FY2023 | 2023-12-31 | (864.66K) | +49.0% |
| FY2022 | 2022-12-31 | (1.7M) | -646.3% |
| FY2021 | 2021-12-31 | 310.49K | — |
Free Cash Flow vs competitors
How TGEN compares with its peers on the latest reported figures
- TGEN's LTM Mar 2026 free cash flow of $12.16M is the 7th largest of the 11 companies compared; the peer median is $3.09M.
- Its year-over-year change of -840.3% is the lowest of 10, against a peer median of +113.7%.
- Free cash flow amounts to 46.5% of revenue for TGEN, versus a peer median of 6.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
BNCCEA Industries Inc. Common Stock | LTM Apr 2026 | $263.27M | — | — | 189.8% |
| LTM Mar 2026 | $74.86M | -1.7% | -3.4% | 398.1% | |
| LTM Mar 2026 | $52.42M | +134.3% | — | 24.4% | |
| LTM Mar 2026 | $35.05M | +323.0% | — | 6.2% | |
| LTM Mar 2026 | $34.03M | +1047.9% | +1.7% | 48.1% | |
| LTM Mar 2026 | $28.2M | +391.4% | -22.4% | 3.2% | |
| LTM Mar 2026 | $12.16M | -840.3% | +82.5% | 46.5% | |
| LTM Mar 2026 | $8.09M | -54.5% | +25.7% | — | |
| LTM Mar 2026 | $4.2M | +113.7% | — | 2.6% | |
| LTM Mar 2026 | $1.99M | -95.4% | -68.1% | 0.3% | |
| LTM Mar 2026 | $400K | +102.8% | — | 0.0% | |
| Peer median (excluding TGEN) | $3.09M | +113.7% | -3.4% | 6.2% | |
Competitors are the stored peer set for TGEN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 3.74M | (2.4M) | (4.52M) | (4.67M) | (8.25M) |
| Depreciation & Amortization | 469.85K | 428.35K | 567.71K | 553.78K | 877.68K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 202.43K | 334.15K | 250.39K | 172.99K | 348.03K |
| Change in Working Capital | 941.2K | 153.28K | 1.61M | 7.54M | (4.2M) |
| Accounts Receivables | 1.07M | 3.85M | (24.2K) | 1.47M | 1.94M |
| Inventory | (596.39K) | (2.82M) | (82.53K) | 848.88K | (1.43M) |
| Accounts Payables | (674.75K) | (246.4K) | 1.16M | (371.74K) | (761.13K) |
| Other Working Capital | 1.15M | (630.34K) | 557.94K | 5.6M | (3.96M) |
| Other Non-Cash Items | (4.89M) | 130.01K | 1.27M | 466.68K | 1.31M |
| Operating Cash Flow | 465.03K | (1.35M) | (817.81K) | 4.06M | (9.91M) |
| Capital Expenditures | (154.55K) | (344.38K) | (46.85K) | (969.16K) | (400.78K) |
| Acquisitions (Net) | 0 | 0 | (170K) | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 11.64K | 0 | 0 | 0 | (3.69K) |
| Other Investing Activities | (135.24K) | (33.69K) | (28.04K) | (45.57K) | (59.66K) |
| Investing Cash Flow | (215.06K) | (348.57K) | (244.89K) | (1.01M) | (464.13K) |
| Debt Repayment | 1.87M | 0 | 500K | 937.15K | (1.4M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 18.8M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 71K | 0 |
| Financing Cash Flow | 1.87M | 0 | 500K | 1.01M | 17.4M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 2.12M | (1.7M) | (562.7K) | 4.05M | 7.03M |
| Free Cash Flow | 310.49K | (1.7M) | (864.66K) | 3.09M | (10.31M) |
Tecogen Inc.
AMEX:TGEN
Intrinsic Alpha fair value
Locked
Current Price
$1.77
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.